Scientists discover a hidden hereditary form of aggressive prostate cancer
Thursday, November 19, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
Scientists have discovered a rare inherited mutation in the CDK12 gene linked to aggressive prostate cancer, with all five identified carriers developing metastatic disease between ages 44 and 62. The finding could lead to expanded genetic testing, helping families uncover hidden cancer risks and potentially detect the disease while it is still treatable. (via Science Daily)
Read the Full StoryThis article will expire in 29 days.
In the News...
View All Recent News
- Scientists discover a hidden hereditary form of aggressive prostate cancer
- Too much exercise could leave your brain stuck in overdrive
- Why don't weight-loss drugs like Ozempic and Wegovy work for everyone?
- Why do farts smell so bad? The secret is brewing in your gut
- Is free will an illusion? New brain research reveals a surprising twist
- Scientists tested 212 plant-based foods. Every single one contained fungal toxins
- MIT discovers that aging weakens the brain’s nighttime cleaning system
- A little-known protein could be a powerful weapon against Alzheimer’s
- Autistic brains look surprisingly similar on average. Then scientists looked closer.
- Tiny magnets deep inside the brain could transform Parkinson’s treatment
- Why obesity affects men and women differently may be hiding in their fat
- A rare disease reveals a hidden flaw in the immune system
- Scientists tracked kids for 8 years. What they found about screen time was surprising
- Wine, beer, or spirits? Massive study reveals a surprising health divide
- Cannabis addiction linked to 57% higher odds of suicidal thoughts
- The hidden language of psychopathy is not what scientists expected
- Ozempic and Mounjaro may have a surprising effect on your brain
- A hidden biological divide may help explain Alzheimer’s and chronic pain
- Scientists discover that the heart doesn't age the way we thought
- Vitamin B12 may hold the key to treating a rare genetic disorder